HSPA9 and neoplasm: Furthermore, dual targeting of mortalin (HSC70) and HSP72 inhibits HSP90, which plays a key role in ensuring the correct conformation, stability, and activity of many well-defined oncogenic client proteins, ultimately resulting in the induction of tumor-specific apoptosis (Powers et al., 2008).